Search Results - "Lievano, Paola"

RIT with ^(90)Y-Ibritumomab Tiuxetan in Follicular Non-Hodgkin Lymphoma: Evaluation of Recent Outcomes in a Single Institution by Campos, Marcio Miguel Andrade, Limon, Anel E. Montes, Grasa, Jose Maria, Lievano, Paola, Baringo, Teresa, Giraldo, Pilar

Get full text

Long-term complication in follicular lymphoma: assessing the risk of secondary neoplasm in 242 patients treated or not with 90-yttrium-ibritumomab-tiuxetan by Andrade-Campos, Marcio Miguel, Liévano, Paola, Espinosa-Lara, Natalia, Soro-Alcubierre, Gloria, Grasa-Ulrich, José María, López-Gómez, Luis, Baringo, Teresa, Giraldo, Pilar

“…Background Non‐Hodgkin lymphoma patients have a 25% increased risk of secondary primary neoplasms (SPNs). Regarding the controversy about the increased risk of…”
Get full text

90Y-Ibritumomab-Tiuxetan Consolidation in First-Line Complete Response Follicular Lymphoma Patients. Single Center Outcomes Analysis after Five Years Median Follow-up by Andrade-Campos, Marcio, Espinosa-Lara, Natalia, Lievano, Paola, Lopez-Gomez, Luis, Baringo, Teresa, Giraldo, Pilar

“…Introduction: Follicular lymphoma (FL) is the second most common non-Hodgkin lymphoma accounting for around 22% of them. Their natural history is characterized…”
Get full text

Patients Older Than 65 Years With Non-Hodgkin Lymphoma Are Suitable for Treatment With 90Yttrium-Ibritumumab Tiuxetan: A Single-Institution Experience by Andrade-Campos, Marcio M., Montes-Limón, Anel E., Soro-Alcubierre, Gloria, Lievano, Paola, López-Gómez, Luis, Baringo, Teresa, Giraldo, Pilar

“…Radioimmunotherapy in B-cell malignances is currently recommended as consolidation and salvage therapy, depending on the lymphoma subtype. However, the major…”
Get full text

Patients Older Than 65 Years With Non-Hodgkin Lymphoma Are Suitable for Treatment With90 Yttrium-Ibritumumab Tiuxetan: A Single-Institution Experience by Andrade-Campos, Marcio M, Montes-Limón, Anel E, Soro-Alcubierre, Gloria, Lievano, Paola, López-Gómez, Luis, Baringo, Teresa, Giraldo, Pilar

“…Micro-Abstract Radioimmunotherapy in B-cell malignances is currently recommended as consolidation and salvage therapy, depending on the lymphoma subtype…”
Get full text

Patients Older Than 65 Years With Non-Hodgkin Lymphoma Are Suitable for Treatment With (90)Yttrium-Ibritumumab Tiuxetan: A Single-Institution Experience by Andrade-Campos, Marcio M, Montes-Limón, Anel E, Soro-Alcubierre, Gloria, Lievano, Paola, López-Gómez, Luis, Baringo, Teresa, Giraldo, Pilar

“…The mean age of patients included in clinical trials does not reflect the current clinical practice for patients with B-cell non-Hodgkin lymphoma (B-NHL). We…”
Get full text

Tumoural denervation of the nigrostriatal pathway by Añaños, Martin Victor, Baringo, Teresa, Lievano, Paola, De la Cueva, Leticia, Navarro, Pablo, Arroyo, Estela, Gonzalez, Mario, Abos, Dolores

Get full text

RIT with Y90-Ibritumomab Tiuxetan in Follicular Non-Hodgkin Lymphoma : Evaluation of Recent Outcomes in a Single Institution by Andrade Campos, Marcio Miguel, Montes Limón, Anel E., Grasa, Jose María, Lievano, Paola, Baringo, Teresa, Giraldo, Pilar

“…Background. Based on historical data we reviewed our hospital clinical database to analyse our updated information and therapy outcomes of follicular…”
Get full text

Determinación de la tonicidad de la solución multipropósito All In One Light by Rivera Rojas, Lucy, Liévano Segundo, Paola, Fernández Gil, Laura

“…Objective: To determine erythrocyte response against the All In One Light multipurpose solution used for cleaning contact lenses. Methodology: 5 mL of each of…”
Get full text

Determinación de la tonicidad de la solución multipropósito All In One Light by Fernández Gil, Laura, Liévano, Paola Andrea, Rivera Rojas, Lucy

“…Objetivo: determinar la respuesta de los eritrocitos frente a la solución multipropósito All In One Light, empleada para la limpieza de lentes de contacto…”
Get full text